NFKB1 and breast carcinoma: Hagan et al. (2005) noted the potential role of NF-kB because the downregulation of RKIP in MCF7 breast carcinoma cell lines resulted in enhanced phosphorylation and degradation of IkB, which ultimately activates the NF-kB pathway [186].